{"schema_version":"1","generated_at":"2026-11-01T21:53:15.717Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/dolly-aguilera","json_url":"https://www.findmykol.com/kol/dolly-aguilera/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"dolly-aguilera","name":"Dolly Aguilera","credential":"MD","title":"Assistant Professor of Pediatrics, Peds Neuro-Oncology (Emory University)","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Leukemia","Sarcoma","Lung"],"institution":"Emory University","institution_url":"https://www.findmykol.com/institution/emory-university","city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1588811004","orcid":"0000-0001-9668-8177","openalex":"A5054513201"},"summary":"Dolly Aguilera is Assistant Professor of Pediatrics, Peds Neuro-Oncology (Emory University) at Emory University. OpenAlex indexes 110 publications with 1,536 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.","overview":{"text":"Dolly Aguilera, MD, is Assistant Professor of Pediatrics, Peds Neuro-Oncology (Emory University). The public record shows 110 publications with 1,536 citations (h-index 22), centered on Glioma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Sarcoma Diagnosis and Treatment. It also documents an investigator role on 2 registered clinical trials.","bullets":["Top research focus: Glioma Diagnosis and Treatment","2 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-01"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":2,"topics":1,"strength":7},{"label":"Glioma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Astrocytoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":2,"strength":2},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Acute Lymphoblastic Leukemia research","Sarcoma Diagnosis and Treatment","Acute Myeloid Leukemia Research","Lung Cancer Treatments and Mutations"],"works_with":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Emory University","trials":1,"payments":0,"mentions":1},{"name":"National Cancer Institute (NCI)","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":110,"cited_by_count":1536,"h_index":22,"i10_index":34,"pubmed_count":4,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05099003","title":"A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT05099003","trial_url":"https://www.findmykol.com/trial/NCT05099003"},{"nct":"NCT02343224","title":"Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Emory University","source_url":"https://clinicaltrials.gov/study/NCT02343224","trial_url":"https://www.findmykol.com/trial/NCT02343224"}],"source":"trials"},"payments":{"company_count":0,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1588811004","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":9,"years":{"first":2007,"last":2024},"societies":["AACR","ASCO"],"shown":3,"withheld":6,"rows":[{"title":"Abstract B065: A phase 1 study of abemaciclib, a CDK 4/6 inhibitor, with radiation in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)","society":"AACR","meeting":"AACR (meeting unresolved)","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.pediatric24-b065","source_url":"https://doi.org/10.1158/1538-7445.pediatric24-b065","status":"verified"},{"title":"A phase 2 study of sirolimus in combination with metronomic chemotherapy (CHOAnome) in children with recurrent and/or refractory solid and CNS tumors.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2023,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.10024","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.10024","status":"verified"},{"title":"Window-of-opportunity study of ONC201 in pediatric patients with diffuse intrinsic pontine glioma (DIPG) and thalamic glioma.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2022,"role":"co_author","presentation_type":"poster","contribution_type":"trials_in_progress","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps2082","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps2082","status":"verified"}],"source":"congress"},"publications":{"total":4,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Salvage therapies for first relapse of SHH medulloblastoma in early childhood","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf092","status":"verified"},{"title":"ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.01134","status":"verified"},{"title":"Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma","year":2024,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noae001","status":"verified"},{"title":"Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions","year":2024,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-24-0581","status":"verified"},{"title":"Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case Report","year":2024,"journal":"Current Oncology","source_url":"https://doi.org/10.3390/curroncol31010041","status":"verified"}],"most_cited":{"total":110,"shown":5,"withheld":105,"rows":[{"title":"Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma","year":2018,"cited_by_count":129,"type":"article","source_url":"https://doi.org/10.1093/neuonc/noy070"},{"title":"ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma","year":2024,"cited_by_count":120,"type":"article","source_url":"https://doi.org/10.1200/jco.23.01134"},{"title":"Valproic acid induces p21 and topoisomerase-II (α/β) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines","year":2007,"cited_by_count":102,"type":"article","source_url":"https://doi.org/10.1007/s11060-007-9402-7"},{"title":"Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience","year":2013,"cited_by_count":79,"type":"article","source_url":"https://doi.org/10.1007/s00381-012-2013-4"},{"title":"The rationale for targeted therapies in medulloblastoma","year":2013,"cited_by_count":66,"type":"review","source_url":"https://doi.org/10.1093/neuonc/not147"}]},"source":"works"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Tobey J. MacDonald","coauthored_works":48},{"name":"Robert Craig Castellino","coauthored_works":36},{"name":"Claire Mazewski","coauthored_works":33,"profile_url":"https://www.findmykol.com/kol/claire-mazewski"}],"source":"works"},"presence":{"mentions":{"total":1,"shown":1,"rows":[{"url":"https://med.emory.edu/departments/pediatrics/divisions/hematology/profile/?u=DAGUILE","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, Pontificia Universidad Javeriana (medical school)","source_url":"https://www.choa.org/doctors/dolly-g-aguilera","status":"provisional","collected_at":"2026-11-01"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Children's Physician Group (Children's Healthcare of Atlanta)","source_url":"https://www.choa.org/doctors/dolly-g-aguilera","status":"verified","collected_at":"2026-11-01"},{"value":"Aflac Cancer and Blood Disorders Center, Scottish Rite (Children's Healthcare of Atlanta)","source_url":"https://www.choa.org/doctors/dolly-g-aguilera","status":"verified","collected_at":"2026-11-01"}]}},"similar":[{"name":"James Lah","slug":"james-lah","institution":"Emory University","specialty":"Neurology","url":"https://www.findmykol.com/kol/james-lah","json_url":"https://www.findmykol.com/kol/james-lah/profile.json"},{"name":"Keith Delman","slug":"keith-delman","institution":"Emory University","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/keith-delman","json_url":"https://www.findmykol.com/kol/keith-delman/profile.json"},{"name":"John Puskas","slug":"john-puskas","institution":"Emory University","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/john-puskas","json_url":"https://www.findmykol.com/kol/john-puskas/profile.json"},{"name":"Jack Arbiser","slug":"jack-arbiser","institution":"Emory University","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jack-arbiser","json_url":"https://www.findmykol.com/kol/jack-arbiser/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":6,"publications":45,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-01"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-01"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-01"}},"methodology_url":"https://www.findmykol.com/about#methodology"}